| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 156925-25-6 | 枸櫞酸莫沙必利; 4-氨基-5-氯-2-乙氧基-N-[[4-[(4-氟苯基)甲基]嗎啉-2-基]甲基]苯甲酰胺檸檬酸鹽二水物 | Mosapride citrate dihydrate; 4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide citrate dihydrate |  | C27H37ClFN3O12 | 詳情 | 供應(yīng)商 |
| 170729-79-0 | [2R-[2aR*),3a]-2-[1-[3,5-雙(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)嗎啉 | [2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine; 2R-[2α(S*),3α]]-2-[1-[3,5-bis(trifluoromethyl)phenyl]; [2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine; |  | C20H18F7NO2 | 詳情 | 供應(yīng)商 |
| 170729-80-3 | 阿瑞吡坦; 阿瑞匹坦; 5-[2(R)-[1(R)-[3,5-二(三氟甲基)苯基]乙氧基]-3(S)-(4-氟苯基)嗎啉-4-基甲基]-3,4-二氫 | Aprepitant; 5-[2(R)-[1(R)-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-ylmethyl]-3,4-dihydro-2H-1,2,4-triazol-3-one |  | C23H21F7N4O3 | 詳情 | 供應(yīng)商 |
| 172673-20-0 | 福沙吡坦; [3-[[(2R,3S)-2-[(1R)-1-[3,5-雙(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)-4-嗎啉基]甲基]-2,5-二氫-5 | Fosaprepitant; [3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonic acid |  | C23H22F7N4O6P | 詳情 | 供應(yīng)商 |
| 184475-35-2 | 吉非替尼; N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-嗎啉-4-丙氧基)喹唑啉-4-胺 | Gefitinib; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine |  | C22H24ClFN4O3 | 詳情 | 供應(yīng)商 |
| 184475-55-6 | 鹽酸吉非替尼; 4-(3-氯-4-氟苯基氨基)-7-甲氧基-6-[3-(4-嗎啉基)丙氧基]喹唑啉鹽酸鹽 | Gefitinib hydrochloride; 4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride |  | C22H25Cl2FN4O3 | 詳情 | 供應(yīng)商 |
| 184475-56-7 | 吉非替尼二鹽酸鹽; 4-(3-氯-4-氟苯基氨基)-7-甲氧基-6-[3-(4-嗎啉基)丙氧基]喹唑啉二鹽酸鹽 | Gefitinib dihydrochloride; 4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline dihydrochloride |  | C22H26Cl3FN4O3 | 詳情 | 供應(yīng)商 |
| 289499-45-2 | 卡紐替尼二鹽酸鹽; N-[4-[(3-氯-4-氟苯基)氨基]-7-(3-嗎啉-4-基丙氧基)喹唑啉-6-基]丙-2-烯酰胺二鹽酸鹽 | Canertinib dihydrochloride; N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride |  | C24H27Cl3FN5O3 | 詳情 | 供應(yīng)商 |
| 211867-47-9 | 氟嗎啉; 滅克; 4-[3-(3,4-二甲氧基苯基)-3-(4-氟苯基)丙烯酰]嗎啉 | flumorph; 4-[3-(3,4-dimethoxyphenyl)-3-(4-fluorophenyl)-1-oxo-2-propenyl]morpholine; (EZ)-4-[3-(3,4-dimethoxyphenyl)-3-(4-fluorophenyl)acryloyl]morpholine |  | C21H22FNO4 | 詳情 | 供應(yīng)商 |
| 109461-46-3 | 2-(4-氟苯基)-2-甲基嗎啉 | Morpholine,2-(4-fluorophenyl)-2-methyl-; 2-(4-FLUOROPHENYL)-2-METHYLMORPHOLINE |  | C11H14FNO | 詳情 | 供應(yīng)商 |
| 171338-27-5 | (2R,3S)-2-[(1R)-1-[3,5-雙(三氟甲基)苯基)乙氧基]-3-(4-氟苯基)嗎啉 | Morpholine,2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-, (2R,3S)-; Morpholine,2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-, [2R-[2a(R*),3a]]-; |  | C20H18F7NO2 | 詳情 | 供應(yīng)商 |
| 171482-05-6 | (2R,3S)-2-[(1R)-1-[3,5-雙(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)-嗎啉鹽酸鹽 | (2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE; (2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE; (2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride (1:1) |  | C20H19ClF7NO2 | 詳情 | 供應(yīng)商 |
| 849217-64-7 | N-[3-氟-4-[[6-甲氧基-7-[[3-(嗎啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)環(huán)丙烷-1,1-二甲酰胺; N- | GSK 1363089; Foretinib; GSK 1363089; EXEL-2880; XL880; N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL880(GSK1363089) | 無 | C34H34F2N4O6 | 詳情 | 供應(yīng)商 |
| 1229236-86-5 | LY 2784544; 3-[(4-氯-2-氟苯基)甲基]-2-甲基-N-(5-甲基-1H-吡唑-3-基)-8-(4-嗎啉甲基)咪唑并[1,2-B]噠嗪-6- | LY 2784544; LY 2784544; 3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine | 無 | C23H25ClFN7O | 詳情 | 供應(yīng)商 |